Successful third Eurobond issue for Mölnlycke

Successful third Eurobond issue for Mölnlycke

2월 7 2017

Mölnlycke Health Care, a world-leading medical solutions company, successfully launched on 6 February a EUR 500 million bond, maturing in February 2025, with an annual fixed coupon of 1,875%.

Following a well-attended road show in December 2016, there was strong and widespread investor demand for the bond issue, which was more than 5 times oversubscribed. “This reconfirms market confidence in Mölnlycke and our sound, long-term corporate strategy”, said Stefan Fristedt, CFO.

The bond issue will be used for general corporate purposes and will enable Mölnlycke to extend its debt maturity profile at an attractive cost, increase financial flexibility and support the Group’s continued growth. The company will stay well within its financial leverage policy after the bond issue.

Demand came from leading investors in all regions: Germany/Austria 44%, the Nordics 16%, UK/Ireland 15%, France 13%, Switzerland 5%, BeNeLux 4% and Other 3%. Asset managers were the leading investor type with 74%, followed by insurance/pension funds with 11%, while banks contributed with 10%, official institutions and other with 5%.

For more information, please contact Stefan Fristedt, CFO, +46 31 352 3746.

Press contact

Bodil Czarnecki
Corporate Communications

Direct: +46 31 722 30 37
Mobile: +46 739 41 25 37

Contact form